Transcat's (TRNS) "Buy" Rating Reaffirmed at HC Wainwright

Key Points

• HC Wainwright has restated a "buy" rating for Transcat (NASDAQ:TRNS) with a price objective of $116.00, indicating a potential upswing of 34.84% from its previous close.
• Transcat's recent quarterly earnings report showed an EPS of $0.59, exceeding analyst expectations of $0.40 with revenues of $76.42 million.
• Institutional investors hold a significant stake in Transcat, with 98.34% of the company's stock owned by this group as of recent reports.

HC Wainwright restated their buy rating on shares of Transcat (NASDAQ:TRNS - Free Report) in a report issued on Friday morning,Benzinga reports. They currently have a $116.00 target price on the scientific and technical instruments company's stock. HC Wainwright also issued estimates for Transcat's FY2027 earnings at $2.45 EPS.

Several other brokerages have also issued reports on TRNS. Lake Street Capital began coverage on Transcat in a research note on Thursday, July 10th. They issued a "buy" rating and a $105.00 price target on the stock. Wall Street Zen raised Transcat from a "sell" rating to a "hold" rating in a report on Wednesday, May 28th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $112.20.

Transcat Trading Up 1.8%

NASDAQ:TRNS traded up $1.44 on Friday, hitting $82.98. 64,215 shares of the stock were exchanged, compared to its average volume of 106,134. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.36 and a current ratio of 2.92. The stock has a market capitalization of $773.37 million, a price-to-earnings ratio of 58.03 and a beta of 0.71. The company's 50-day moving average price is $83.06 and its 200 day moving average price is $80.80. Transcat has a 52 week low of $67.56 and a 52 week high of $133.72.

Transcat (NASDAQ:TRNS - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The scientific and technical instruments company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.40 by $0.19. Transcat had a return on equity of 6.66% and a net margin of 4.64%.The company had revenue of $76.42 million during the quarter, compared to the consensus estimate of $72.28 million. On average, equities research analysts forecast that Transcat will post 2.3 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the business. Conestoga Capital Advisors LLC lifted its holdings in Transcat by 13.7% during the second quarter. Conestoga Capital Advisors LLC now owns 1,088,471 shares of the scientific and technical instruments company's stock worth $93,565,000 after buying an additional 131,217 shares during the period. Neuberger Berman Group LLC increased its holdings in shares of Transcat by 5.5% in the first quarter. Neuberger Berman Group LLC now owns 921,898 shares of the scientific and technical instruments company's stock valued at $68,635,000 after purchasing an additional 47,913 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its holdings in Transcat by 17.1% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 607,360 shares of the scientific and technical instruments company's stock valued at $45,218,000 after buying an additional 88,763 shares in the last quarter. Champlain Investment Partners LLC grew its holdings in shares of Transcat by 7.6% during the 1st quarter. Champlain Investment Partners LLC now owns 598,026 shares of the scientific and technical instruments company's stock worth $44,523,000 after purchasing an additional 42,376 shares during the period. Finally, Royce & Associates LP lifted its stake in Transcat by 1.1% during the 1st quarter. Royce & Associates LP now owns 478,581 shares of the scientific and technical instruments company's stock worth $35,630,000 after acquiring an additional 5,327 shares in the last quarter. Institutional investors own 98.34% of the company's stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.